Epinephrine Auto-Injector Market Research Report 2022 – Global Forecast to 2027: Increase in the Demand for Self-Management of Anaphylaxis – ResearchAndMarkets.com

Epinephrine Auto-Injector Market Research Report 2022 – Global Forecast to 2027: Increase in the Demand for Self-Management of Anaphylaxis – ResearchAndMarkets.com

Epinephrine Auto-Injector Market Research Report 2022 – Global Forecast to 2027: Increase in the Demand for Self-Management of Anaphylaxis – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Epinephrine Auto-Injector Market Research Report by Dosage, End-User, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering.

The Global Epinephrine Auto-Injector Market size was estimated at USD 292.68 million in 2021, USD 320.33 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 9.62% to reach USD 508.04 million by 2027.

In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects.

It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Epinephrine Auto-Injector Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space.

It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors.

The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

  • ALK-Abello A/S
  • Amedra Pharmaceuticals LLC
  • Amgen Inc.
  • Amneal Pharmaceuticals Inc.
  • Antares Pharma Inc.
  • Bausch Health Companies, Inc.
  • Bayer AG
  • Becton, Dickinson and Company
  • BPI Labs, Inc.
  • Eli Lilly and Company
  • GlaxoSmithKline PLC
  • Hospice Inc
  • Hospira Inc.
  • Impax Laboratories, Inc.
  • Janssen Global Services, LLC
  • Kaleo, Inc.
  • Lincoln Medical Centre Ltd.
  • Lincoln Medical Ltd
  • Merck KGaA
  • Mylan Inc
  • Novartis International AG
  • Pfizer, Inc.
  • Sanofi SA
  • Teva Pharmaceuticals Lts
  • Ypsomed Holding

Key Topics Covered:

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics

5.1.1. Drivers Growing awareness about allergies Technological developments in research & development activities High demand for autoinjectors instead of conventional devices such as standard syringes

5.1.2. Restraints High cost of epinephrine auto injector

5.1.3. Opportunities Demand for easy usability of disposable drug injectors Increase in the demand for self-management of anaphylaxis

5.1.4. Challenges Stringent regulations imposed by the government

5.2. Cumulative Impact of COVID-19

5.3. Cumulative Impact of 2022 Russia Ukraine Conflict

6. Epinephrine Auto-Injector Market, by Dosage

6.1. Introduction

6.2. 0.3 Mg Epinephrine Autoinjector

6.3. 0.5 Mg Epinephrine Autoinjector

6.4. Mg Epinephrine Autoinjector

7. Epinephrine Auto-Injector Market, by End-User

7.1. Introduction

7.2. Clinics

7.3. Hospital

7.4. Individual

8. Americas Epinephrine Auto-Injector Market

8.1. Introduction

8.2. Argentina

8.3. Brazil

8.4. Canada

8.5. Mexico

8.6. United States

9. Asia-Pacific Epinephrine Auto-Injector Market

9.1. Introduction

9.2. Australia

9.3. China

9.4. India

9.5. Indonesia

9.6. Japan

9.7. Malaysia

9.8. Philippines

9.9. Singapore

9.10. South Korea

9.11. Taiwan

9.12. Thailand

10. Europe, Middle East & Africa Epinephrine Auto-Injector Market

10.1. Introduction

10.2. France

10.3. Germany

10.4. Italy

10.5. Netherlands

10.6. Qatar

10.7. Russia

10.8. Saudi Arabia

10.9. South Africa

10.10. Spain

10.11. United Arab Emirates

10.12. United Kingdom

11. Competitive Landscape

11.1. FPNV Positioning Matrix

11.1.1. Quadrants

11.1.2. Business Strategy

11.1.3. Product Satisfaction

11.2. Market Ranking Analysis

11.3. Market Share Analysis, By Key Player

11.4. Competitive Scenario

11.4.1. Merger & Acquisition

11.4.2. Agreement, Collaboration, & Partnership

11.4.3. New Product Launch & Enhancement

11.4.4. Investment & Funding

11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles

For more information about this report visit https://www.researchandmarkets.com/r/srj052



Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900